IGN523

· Igenica Biotherapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IGN523, covering 2016-02-23 to 2016-02-23. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Study of IGN523 in Subjects With Relapsed or Refractory AML [Phase 1]